119 related articles for article (PubMed ID: 36273737)
1. External validation of a composite bio-humoral index in anal cancer patients undergoing concurrent chemoradiation.
Franco P; Porreca A; Mantello G; Valvo F; Gasparini L; Slim N; Manfrida S; De Felice F; Gerardi MA; Vagge S; Krengli M; Palazzari E; Osti MF; Gonnelli A; Catalano G; Pittoni P; Ivaldi GB; Lupattelli M; Rosetto ME; Niespolo RM; Guido A; Durante O; Macchia G; Munoz F; El Khouzai B; Lucido MR; Arcadipane F; Casadei Gardini A; Maria D'Angelillo R; Gambacorta MA; Genovesi D; Di Nicola M; Caravatta L
Radiother Oncol; 2022 Dec; 177():9-15. PubMed ID: 36273737
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of the New Combined Hemo-Eosinophil Inflammation Index (HEI Index): A Multicenter Analysis of Anal Cancer Patients Treated with Concurrent Chemo-Radiation.
Rimini M; Franco P; De Bari B; Zampino MG; Vagge S; Frassinetti GL; Arcadipane F; Bacigalupo A; Valgiusti M; Aloi D; Gervaso L; Corvò R; Bartolini G; Gerardi MA; Cascinu S; Casadei-Gardini A
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562397
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG).
Martin D; Schreckenbach T; Ziegler P; Filmann N; Kalinauskaite G; Tinhofer I; Budach V; Gani C; Zips D; Schimek-Jasch T; Schäfer H; Grosu AL; Thomas E; Krause M; Dapper H; Combs S; Hoffmann C; Stuschke M; Walter F; Belka C; Kurth I; Hadiwikarta WW; Baumann M; Rödel C; Fokas E
Radiother Oncol; 2022 Feb; 167():233-238. PubMed ID: 34999135
[TBL] [Abstract][Full Text] [Related]
4. Anal Squamous Cell Carcinoma: Radiation Therapy Alone Must Be Avoided.
Almaazmi H; Taylor JP; Stem M; Yu D; Lo BD; Safar B; Efron JE
J Surg Res; 2020 Mar; 247():530-540. PubMed ID: 31648811
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.
Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW
Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622
[TBL] [Abstract][Full Text] [Related]
6. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Role of Baseline Eosinophils in HPV-Related Cancers: a Multi-institutional Analysis of Anal SCC and OPC Patients Treated with Radical CT-RT.
Rimini M; Franco P; Bertolini F; Berardino B; Giulia ZM; Stefano V; Andrikou K; Arcadipane F; Napolitano M; Buno LV; Alessandra GM; Olivero F; Ferreri F; Ricardi U; Cascinu S; Casadei-Gardini A
J Gastrointest Cancer; 2023 Jun; 54(2):662-671. PubMed ID: 35915202
[TBL] [Abstract][Full Text] [Related]
8. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis.
Hong J; Liao Z; Zhuang Y; Levy LB; Sheu T; Heymach JV; Nguyen QN; Xu T; Komaki R; Gomez DR
Am J Clin Oncol; 2018 Jan; 41(1):46-52. PubMed ID: 26535988
[TBL] [Abstract][Full Text] [Related]
11. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Gunderson LL; Winter KA; Ajani JA; Pedersen JE; Moughan J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett CG
J Clin Oncol; 2012 Dec; 30(35):4344-51. PubMed ID: 23150707
[TBL] [Abstract][Full Text] [Related]
12. Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review.
Abdelazim YA; Rushing CN; Palta M; Willett CG; Czito BG
Cancer; 2019 Jun; 125(12):2115-2122. PubMed ID: 30825391
[TBL] [Abstract][Full Text] [Related]
13. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
[No Abstract] [Full Text] [Related]
14. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.
Hocquelet A; Auriac T; Perier C; Dromain C; Meyer M; Pinaquy JB; Denys A; Trillaud H; Denis De Senneville B; Vendrely V
Eur Radiol; 2018 Jul; 28(7):2801-2811. PubMed ID: 29404766
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric Cohort.
Iseas S; Prost D; Bouchereau S; Golubicki M; Robbio J; Oviedo A; Coraglio M; Kujaruk M; Méndez G; Carballido M; Roca E; Gros L; De Parades V; Baba-Hamed N; Adam J; Abba MC; Raymond E
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979770
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
Yang X; Wang L; Du H; Lin B; Yi J; Wen X; Geng L; Du X
Medicine (Baltimore); 2021 Jan; 100(3):e24328. PubMed ID: 33546064
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
19. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
[TBL] [Abstract][Full Text] [Related]
20. Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
Trilla-Fuertes L; Gámez-Pozo A; Nogué M; Busquier I; Arias F; López-Campos F; Fernández-Montes A; Ruiz A; Velázquez C; Martín-Bravo C; Pérez-Ruiz E; Asensio E; Hernández-Yagüe X; Rodrigues A; Ghanem I; López-Vacas R; Hafez A; Arias P; Dapía I; Solís M; Dittmann A; Ramos R; Llorens C; Maurel J; Campos-Barros Á; Fresno Vara JÁ; Feliu J
Cancer; 2023 Aug; 129(16):2581-2592. PubMed ID: 37096763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
